EP Patent

EP1919456A2 — Bazedoxifene acetate formulations and manufacturing process thereof

Assigned to Wyeth LLC · Expires 2008-05-14 · 18y expired

What this patent protects

The present invention is directed to formulations of bazedoxifene acetate that have reduced polymorph conversion, compositions containing the same, preparations thereof, and uses thereof.

USPTO Abstract

The present invention is directed to formulations of bazedoxifene acetate that have reduced polymorph conversion, compositions containing the same, preparations thereof, and uses thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP1919456A2
Jurisdiction
EP
Classification
—
Expires
2008-05-14
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.